Odds
Yes48%
Market details
Status
void
Positions
4
Volume
220 cr
Locks
Jan 6, 2026
Updated
Dec 24, 2025, 03:19 AM
Rules summary
Resolves YES if Eliquis (apixaban) US WAC monthly price is < $450/month as of Dec 31, 2026. Primary source: sponsor WAC/list price publication or a clearly cited WAC source. Otherwise NO.
Market context
Monthly-metric example to ensure the Rules Summary and measurement fields support variation.
People are also buying
BrowseCommunity vote50% Yes · 0 votes
VoteVoting closed